key articles
Joint EAU-Japanese session examines regenerative SUI technique
Friday, 15 March 2013- Voiding dysfunctions and the regenerative treatment of stress urinary incontinence using autologous adipose-derived stem cells was dexamined by experts during the Joint Session of the European...
By J. Vega
Effects of drug cessation after flexible-dose fesoterodine in OAB patients
Wednesday, 13 March 2013- V. Khullar and colleagues conducted a study to determine the course of overactive bladder (OAB) symptoms after 4 weeks of no treatment following a 12-week study of the efficacy and safety of...
Posted by: JV
Long-term efficacy and safety of OnabotulinumtoxinA in patients with urinary incontinence
Wednesday, 9 January 2013- M. Kenelly and colleagues conducted a study to evaluate the long-term efficacy and safety of repeat onabotulinumtoxinA injections in patients inadequately treated with anticholinergics for urinary...
Posted by: JV
Guidelines to aid family doctors evaluate, manage female urinary incontinence
Tuesday, 18 September 2012- Millions of women experience a loss of bladder control, or urinary incontinence, in their lifetime.
It's a common and often embarrassing problem that many patients don't bring up with their doctors -...
Filed by: JV
New stem cell therapy shows promise in treating Stress Urinary Incontinence
Thursday, 23 August 2012- Stress urinary incontinence (SUI) can occur due to sneezing, coughing, exercising or even laughing and happens because the pelvic floor muscles are too weak causing leakage when the bladder is put under...
Filed by: JV
Links of commonly used drugs with urinary incontinence: a community based sample
Wednesday, 27 June 2012- S. Hall and colleagues conducted to examin the association between the use of medications and the prevalence of urinary incontinence in gender specific analyses of a community based, representative...
Filed by: JV
US study says drugs of limited benefit in treating urine leakage in women
Monday, 16 April 2012- There are few data to show that drugs for urge urinary incontinence improve quality of life or have differences in comparative efficacy, according to a US government-commissioned study.
The review of...
Filed by: JV
FDA advisory panel approves overactive bladder drug
Tuesday, 10 April 2012- An FDA advisory committee has voted 7-4, with one member abstaining, that the benefits of the overactive bladder drug mirabegron outweigh its risks.
The FDA's Reproductive Health Drugs Advisory Committee...
Filed by: JV
FDA warns of cardio risks for overactive bladder drug mirabegron
Thursday, 5 April 2012- Mirabegron, an investigational drug for overactive bladder, is effective at reducing symptoms of urinary incontinence but has worrisome cardiovascular side effects and may be harmful to the liver,...
Filed by: JV
Male sling adjustment: can the retrograde leak point pressure help to reduce postoperative urethral lesions?
Monday, 12 March 2012- M. Rutkowski and W. Hübner conducted a study to evaluate the influence of a retrograde leak point pressure (RLPP) measurement during implantation of an adjustable bulborurethal male sling on the...
Edited by: JV
